Cormorant Pharmaceuticals
Solna
About Cormorant Pharmaceuticals
Cormorant Pharmaceuticals is a privately held, biopharmaceutical company founded by Maarten de Château and Urban Paulsson. The company is based at the Karolinska Institute Science Park in Stockholm, Sweden. Based on mounting research pointing to IL-8 being an important driver of malignant tumors, HuMax-IL8 was acquired from Genmab A/S and taken into development by Cormorant. HuMax-IL8, is a fully human monoclonal antibody
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: cormorantpharma.com
Social Profiles
Canonical: https://fsome.com/organization/cormorant-pharmaceuticals-3059407 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.